A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults

Clinical trial NCT06182124 · COMPLETED

Trial details

NCT number: NCT06182124
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2023-12-20
Primary completion: 2026-05-12
Enrollment: 1363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.